These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 6421875)

  • 1. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct radioimmune detection in human plasma of the association between factor VIII procoagulant protein and von Willebrand factor, and the interaction of von Willebrand factor-bound procoagulant VIII with platelets.
    Moake JL; Weinstein MJ; Troll JH; Chute LE; Colannino NM
    Blood; 1983 Jun; 61(6):1163-73. PubMed ID: 6404328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of low-molecular-weight canine factor VIII coagulant from von Willebrand plasma to canine factor VIII-related antigen.
    Benson RE; Johnson GS; Dodds WJ
    Br J Haematol; 1981 Dec; 49(4):541-50. PubMed ID: 6797460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation.
    Weinstein MJ; Chute LE; Schmitt GW; Hamburger RH; Bauer KA; Troll JH; Janson P; Deykin D
    J Clin Invest; 1985 Oct; 76(4):1406-11. PubMed ID: 3932466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of factor VIII coagulant antigen in normal, thrombin-treated, and hemophilic plasma.
    Weinstein M; Chute L; Deykin D
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5137-41. PubMed ID: 6795628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phospholipid on factor VIII coagulant activity and coagulant antigen.
    Brodén K; Brown JE; Carton C; Andersson LO
    Thromb Res; 1983 Jun; 30(6):651-60. PubMed ID: 6412394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure - function relationship of factor VIII/von Willebrand factor. Application to the study of variant von Willebrand's disease and cryosupernatant prepared from normal plasma.
    Pietu G; Obert B; Larrieu MJ; Meyer D
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):671-85. PubMed ID: 6777898
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor VIII: structure and function in blood clotting.
    Chavin SI
    Am J Hematol; 1984 Apr; 16(3):297-306. PubMed ID: 6424437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.
    Gralnick HR
    J Clin Invest; 1978 Aug; 62(2):496-9. PubMed ID: 307560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine Willebrand factor: a population of multimers.
    Fass DN; Knutson GJ; Bowie EJ
    J Lab Clin Med; 1978 Feb; 91(2):307-20. PubMed ID: 413873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of von Willebrand factor on activation of factor VIII by factor Xa.
    Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ
    Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
    Switzer ME; McKee PA
    J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoradiometric assays for factor VIII antigens: coagulant protein (antihemophilic factor) and factor VIII-related protein (von Willebrand factor).
    Hoyer LW; Trabold NC
    Methods Enzymol; 1982; 84():51-60. PubMed ID: 6808318
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
    Girma JP; Pietu G; Lavergne JM; Meyer D; Larrieu MJ
    J Lab Clin Med; 1982 Apr; 99(4):481-94. PubMed ID: 6174657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of von Willebrand factor: effects of different kinds of carbohydrate oxidases, SH-inhibitors and some other chemical reagents.
    Fukui H; Mikami S; Okuda T; Murashima N; Takase T
    Br J Haematol; 1977 Jun; 36(2):259-70. PubMed ID: 301402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
    Brown JE; Thuy LP; Carton CL; Hougie C
    J Lab Clin Med; 1983 May; 101(5):793-805. PubMed ID: 6403639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein.
    Croissant MP; Zuzel M; Allain JP
    Blood; 1983 Jul; 62(1):133-40. PubMed ID: 6190519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The separation of Willebrand factor from factor VIII-related antigen.
    Barrow ES; Reisner HM; Graham JB
    Br J Haematol; 1979 Jul; 42(3):455-68. PubMed ID: 314303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.